Australia's TGA updates risk management strategy with biologicals regulatory framework
This article was originally published in SRA
Executive Summary
Australia's Therapeutic Goods Administration has updated a document that outlines its broad risk management strategy for therapeutic goods to include the new biologicals regulatory framework that came into effect on 31 May1,2. The framework covers human tissues and cellular therapies3.